SNPS vs XFOR · P/E 63, rev $7.16B vs rev $4.8M
Synopsys Inc (SNPS) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Latest reported XFOR revenue for 2026-06-30 was $4.8M. Net income was -$36.4M. Revenue was up 92.0% from 2026-03-31 to 2026-06-30. XFOR currently screens at market cap $382.0M.
SNPS currently screens at market cap $85.14B and trailing P/E 63.3. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the SNPS and XFOR stock pages for the full models.
Not investment advice.